Track topics on Twitter Track topics that are important to you
Allergan’s partner Heptares Therapeutics has dosed the first patient with a GPCR drug to treat major symptoms of Alzheimer’s disease. A year ago, Allergan signed a massive deal of up to €3Bn with Heptares Therapeutics for the development of drugs ...
This awesome article Allergan Takes to the Clinic the First Alzheimer’s Drug from a €3Bn Deal appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)
Original Article: Allergan Takes to the Clinic the First Alzheimer’s Drug from a €3Bn DealNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...